只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,379 | US$316.26 | US$486.38万 | 46,018 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 20,029 | US$316.91 | US$634.73万 | 25,989 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,842 | US$318.41 | US$249.7万 | 18,147 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,807 | US$319.29 | US$504.7万 | 2,340 | SEC |
| 2026-07-21 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 2,340 | US$320.06 | US$748,936.42 | 0 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 5,146 | US$310.08 | US$159.57万 | 9,180 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,273 | US$310.75 | US$194.93万 | 2,907 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 2,907 | US$311.80 | US$906,388.65 | 0 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,499 | US$312.29 | US$484.01万 | 18,491 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 14,326 | US$312.96 | US$448.34万 | 4,165 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,850 | US$313.91 | US$580,731.65 | 2,315 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,512 | US$315.26 | US$476,677.66 | 803 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 523 | US$316.14 | US$165,339.28 | 280 | SEC |
| 2026-07-20 2026-07-22 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 280 | US$318.30 | US$89,124.00 | 0 | SEC |
| 2026-07-20 2026-07-21 | AKTS Aktis Oncology, Inc. | Herrmann Ken Director | 卖出（S） | 3,506 | US$24.56 | US$86,115.07 | 1,350 | SEC |
| 2026-07-20 2026-07-21 | AKTS Aktis Oncology, Inc. | Herrmann Ken Director | 卖出（S） | 1,350 | US$24.56 | US$33,158.97 | 0 | SEC |
| 2026-07-17 2026-07-20 | AKTS Aktis Oncology, Inc. | Herrmann Ken Director | 卖出（S） | 3,065 | US$25.21 | US$77,258.54 | 0 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,440 | US$305.20 | US$439,485.84 | 63,188 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 597 | US$306.96 | US$183,257.63 | 62,591 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 680 | US$309.05 | US$210,156.79 | 61,911 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,833 | US$310.37 | US$150万 | 57,078 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 5,543 | US$311.42 | US$172.62万 | 51,535 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 35,829 | US$312.17 | US$1118.49万 | 15,706 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 14,915 | US$313.19 | US$467.12万 | 791 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 740 | US$314.32 | US$232,596.65 | 51 | SEC |
| 2026-07-17 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 51 | US$315.06 | US$16,068.18 | 0 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 233 | US$311.98 | US$72,691.34 | 166,364 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,881 | US$314.08 | US$153.3万 | 161,483 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 9,516 | US$314.73 | US$299.5万 | 151,967 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 19,752 | US$316.00 | US$624.16万 | 132,215 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 32,224 | US$316.82 | US$1020.91万 | 99,991 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 42,798 | US$317.79 | US$1360.07万 | 57,193 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,402 | US$318.55 | US$203.94万 | 50,791 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 15,097 | US$319.99 | US$483.09万 | 35,694 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 20,505 | US$321.00 | US$658.21万 | 15,189 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 13,109 | US$321.61 | US$421.6万 | 2,080 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,560 | US$322.71 | US$503,423.86 | 520 | SEC |
| 2026-07-16 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 520 | US$323.59 | US$168,264.62 | 0 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 6,067 | US$310.02 | US$188.09万 | 110,490 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 41,336 | US$310.92 | US$1285.23万 | 69,154 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 12,857 | US$311.71 | US$400.77万 | 56,297 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 48,657 | US$312.86 | US$1522.27万 | 7,640 | SEC |
| 2026-07-15 2026-07-17 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,640 | US$313.58 | US$239.57万 | 0 | SEC |
| 2026-07-15 2026-07-17 | CGON CG Oncology, Inc. | POST LEONARD E Director | 卖出（S） | 1,000 | US$71.17 | US$71,170.00 | 0 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 400 | US$84.37 | US$33,746.00 | 39,318 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 2,497 | US$85.86 | US$214,385.43 | 36,821 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 3,803 | US$86.68 | US$329,630.35 | 33,018 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 300 | US$87.25 | US$26,175.99 | 32,718 | SEC |
| 2026-07-14 2026-07-16 | CRDF Cardiff Oncology, Inc. | Mohindru Mani Director,Officer · Chief Executive Officer | 买入（P） | 34,364 | US$1.46 | US$49,999.62 | 59,067 | SEC |
| 2026-07-14 2026-07-16 | CRDF Cardiff Oncology, Inc. | PACE GARY W Director | 买入（P） | 687,285 | US$1.46 | US$999,999.68 | 2,043,661 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 17,974 | US$6.43 | US$115,554.85 | 259,527 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 5,478 | US$6.35 | US$34,785.30 | 259,527 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,139 | US$303.07 | US$125.44万 | 8,122 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 8,122 | US$303.93 | US$246.85万 | 0 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 39,090 | US$305.02 | US$1192.33万 | 94,510 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 45,895 | US$306.21 | US$1405.36万 | 48,615 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 40,781 | US$306.93 | US$1251.71万 | 7,834 | SEC |
| 2026-07-14 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,834 | US$307.57 | US$240.95万 | 0 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 798 | US$301.94 | US$240,945.25 | 47,722 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 4,584 | US$302.79 | US$138.8万 | 43,138 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 26,294 | US$303.83 | US$798.88万 | 16,844 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 8,438 | US$304.68 | US$257.09万 | 8,406 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 846 | US$305.57 | US$258,508.33 | 7,560 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 7,240 | US$306.82 | US$222.14万 | 320 | SEC |
| 2026-07-13 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 320 | US$307.41 | US$98,369.60 | 0 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,493 | US$296.07 | US$442,028.33 | 10,205 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,314 | US$297.23 | US$390,560.61 | 8,891 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 3,074 | US$298.35 | US$917,132.82 | 5,817 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 5,143 | US$298.94 | US$153.74万 | 674 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 370 | US$300.12 | US$111,044.36 | 304 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 150 | US$301.18 | US$45,177.42 | 154 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 136 | US$302.19 | US$41,097.99 | 18 | SEC |
| 2026-07-10 2026-07-14 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 18 | US$303.03 | US$5,454.54 | 0 | SEC |
| 2026-07-10 2026-07-14 | CGON CG Oncology, Inc. | Mulay James Director | 卖出（S） | 24,165 | US$75.16 | US$181.62万 | 0 | SEC |
| 2026-07-10 2026-07-13 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 15,000 | US$5.85 | US$87,750.00 | 10,630,858 | SEC |
| 2026-07-10 2026-07-13 | BBCP Concrete Pumping Holdings, Inc. | Stevens Brent M Director,TenPercentOwner | 卖出（S） | 97,700 | US$10.83 | US$105.82万 | 497,155 | SEC |
| 2026-07-09 2026-07-13 | BBCP Concrete Pumping Holdings, Inc. | Stevens Brent M Director,TenPercentOwner | 卖出（S） | 2,300 | US$10.78 | US$24,797.45 | 594,855 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 14,800 | US$27.13 | US$401,484.04 | 35,200 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 30,829 | US$27.95 | US$861,735.29 | 4,371 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 4,371 | US$28.71 | US$125,481.79 | 0 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Ron-Bigger Shulamit Officer · Chief Operating Officer | 卖出（S） | 15,800 | US$27.13 | US$428,680.86 | 34,200 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Ron-Bigger Shulamit Officer · Chief Operating Officer | 卖出（S） | 30,000 | US$27.94 | US$838,137.00 | 4,200 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Ron-Bigger Shulamit Officer · Chief Operating Officer | 卖出（S） | 4,200 | US$28.75 | US$120,739.92 | 0 | SEC |
| 2026-07-08 2026-07-10 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 664 | US$302.46 | US$200,833.44 | 0 | SEC |
| 2026-07-08 2026-07-09 | CNXC Concentrix Corp | Caldwell Christopher A Director,Officer · President and CEO | 买入（P） | 1,000 | US$21.25 | US$21,249.70 | 358,382 | SEC |
| 2026-07-01 2026-07-06 | CON Concentra Group Holdings Parent, Inc. | ORTENZIO ROBERT A Director | 卖出（S） | 130,000 | US$30.50 | US$396.46万 | 633,455 | SEC |
| 2026-07-01 2026-07-06 | ALXO ALX ONCOLOGY HOLDINGS INC | Wong Shelly Officer · SVP, FINANCE AND CAO | 卖出（S） | 1,404 | US$2.04 | US$2,864.16 | 88,401 | SEC |
| 2026-07-01 2026-07-02 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 240,000 | US$0.04 | US$10,344.00 | 94,124,319 | SEC |
| 2026-06-30 2026-07-02 | PYXS Pyxis Oncology, Inc. | Dupont Jakob Director | 卖出（S） | 35,000 | US$3.06 | US$107,100.00 | 38,741 | SEC |
| 2026-06-25 2026-06-29 | CGON CG Oncology, Inc. | Liu Brian Guan-Chyun Director | 买入（P） | 371,085 | US$66.87 | US$2481.45万 | 1,886,236 | SEC |
| 2026-06-24 2026-06-25 | CGON CG Oncology, Inc. | POST LEONARD E Director | 卖出（S） | 5,000 | US$70.00 | US$350,000.00 | 0 | SEC |
| 2026-06-24 2026-06-24 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 115,000 | US$0.05 | US$5,750.00 | 93,884,319 | SEC |
| 2026-06-23 2026-06-25 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,290 | US$274.12 | US$353,614.80 | 320 | SEC |
| 2026-06-23 2026-06-25 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 320 | US$275.10 | US$88,032.00 | 0 | SEC |
| 2026-06-23 2026-06-25 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,800 | US$273.30 | US$491,940.00 | 1,610 | SEC |
| 2026-06-23 2026-06-25 | ONC BeOne Medicines Ltd. | Wu Xiaobin Officer · President and COO | 卖出（S） | 1,292 | US$276.26 | US$356,927.92 | 0 | SEC |
| 2026-06-23 2026-06-25 | ONC BeOne Medicines Ltd. | Wang Lai Officer · President, Global Head of R&D | 卖出（S） | 1,068 | US$276.74 | US$295,558.32 | 0 | SEC |
| 2026-06-23 2026-06-24 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 18,000 | US$5.02 | US$90,360.00 | 10,615,858 | SEC |
| 2026-06-23 2026-06-24 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 75,000 | US$0.05 | US$3,750.00 | 93,769,319 | SEC |
| 2026-06-22 2026-06-24 | UTI UNIVERSAL TECHNICAL INSTITUTE INC | Prehn Kevin Officer · Concorde Division President | 卖出（S） | 4,545 | US$40.00 | US$181,800.00 | 27,025 | SEC |
| 2026-06-22 2026-06-24 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 65,000 | US$0.05 | US$3,250.00 | 93,694,319 | SEC |
| 2026-06-22 2026-06-23 | CGON CG Oncology, Inc. | POST LEONARD E Director | 卖出（S） | 5,000 | US$65.00 | US$325,000.00 | 0 | SEC |
| 2026-06-22 2026-06-22 | OTLC Oncotelic Therapeutics, Inc. | Shah Amit B. Officer · CFO | 买入（P） | 20,000 | US$0.05 | US$1,000.00 | 378,837 | SEC |
| 2026-06-18 2026-06-22 | CRDF Cardiff Oncology, Inc. | PACE GARY W Director | 买入（P） | 30,000 | US$1.22 | US$36,600.00 | 1,356,376 | SEC |
| 2026-06-18 2026-06-22 | KURA Kura Oncology, Inc. | Leoni Mollie Officer · Chief Medical Officer | 卖出（S） | 84,929 | US$9.82 | US$834,002.78 | 182,345 | SEC |
| 2026-06-18 2026-06-22 | CRDF Cardiff Oncology, Inc. | Mohindru Mani Director,Officer · Chief Executive Officer | 买入（P） | 24,703 | US$1.21 | US$29,890.63 | 24,703 | SEC |
| 2026-06-17 2026-06-17 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 239,759 | US$0.04 | US$9,590.36 | 93,629,319 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,710 | US$265.99 | US$454,842.90 | 333 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,650 | US$264.87 | US$437,035.50 | 2,043 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 333 | US$266.69 | US$88,807.77 | 0 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | Wu Xiaobin Officer · President and COO | 卖出（S） | 1,357 | US$266.76 | US$361,993.32 | 0 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | Wang Lai Officer · President, Global Head of R&D | 卖出（S） | 1,169 | US$265.39 | US$310,240.91 | 0 | SEC |
| 2026-06-16 2026-06-18 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 590 | US$265.98 | US$156,928.20 | 0 | SEC |
| 2026-06-15 2026-06-17 | OTLC Oncotelic Therapeutics, Inc. | Trieu Vuong Director,Officer,TenPercentOwner · CHAIRMAN AND CEO | 买入（P） | 96,000 | US$0.05 | US$4,800.00 | 93,389,560 | SEC |
| 2026-06-15 2026-06-17 | CAVA CAVA GROUP, INC. | Xenohristos Theodoros Director,Officer · Chief Concept Officer | 卖出（S） | 3,252 | US$89.43 | US$290,826.36 | 324,630 | SEC |
| 2026-06-15 2026-06-16 | CGON CG Oncology, Inc. | Mulay James Director | 卖出（S） | 1,310 | US$60.12 | US$78,757.20 | 0 | SEC |
| 2026-06-15 2026-06-16 | CGON CG Oncology, Inc. | Mulay James Director | 卖出（S） | 654 | US$60.12 | US$39,318.48 | 0 | SEC |
| 2026-06-15 2026-06-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 947 | US$69.69 | US$65,996.43 | 32,718 | SEC |
| 2026-06-15 2026-06-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 5,064 | US$69.42 | US$351,542.88 | 33,965 | SEC |
| 2026-06-15 2026-06-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 300 | US$70.62 | US$21,186.00 | 33,665 | SEC |
| 2026-06-15 2026-06-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 1,636 | US$68.38 | US$111,869.68 | 39,029 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 741 | US$256.23 | US$189,866.43 | 1,208 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 859 | US$257.59 | US$221,269.81 | 349 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 200 | US$258.28 | US$51,656.00 | 149 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 149 | US$258.81 | US$38,562.69 | 0 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Ball Titus B. Officer · Principal Accounting Officer | 卖出（S） | 120 | US$257.53 | US$30,903.60 | 0 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Ball Titus B. Officer · Principal Accounting Officer | 卖出（S） | 49 | US$256.39 | US$12,563.11 | 120 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Wu Xiaobin Officer · President and COO | 卖出（S） | 626 | US$261.20 | US$163,511.20 | 0 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Wang Lai Officer · President, Global Head of R&D | 卖出（S） | 756 | US$261.00 | US$197,316.00 | 0 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 428 | US$257.64 | US$110,269.92 | 0 | SEC |
| 2026-06-11 2026-06-15 | ONC BeOne Medicines Ltd. | Rosenberg Aaron Officer · Chief Financial Officer | 卖出（S） | 631 | US$257.74 | US$162,633.94 | 0 | SEC |
| 2026-06-11 2026-06-12 | SR SPIRE INC | KOONCE PAUL D Director | 买入（P） | 500 | US$78.46 | US$39,230.00 | 8,000 | SEC |
| 2026-06-11 2026-06-12 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 9,891 | US$4.04 | US$39,959.64 | 7,348,439 | SEC |
| 2026-06-11 2026-06-12 | BBCP Concrete Pumping Holdings, Inc. | Humphries Iain Director,Officer · CFO and Secretary | 卖出（S） | 96,955 | US$10.79 | US$104.61万 | 377,812 | SEC |
| 2026-06-11 2026-06-11 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 22,887 | US$4.04 | US$92,463.48 | 7,376,150 | SEC |
| 2026-06-11 2026-06-11 | BBCP Concrete Pumping Holdings, Inc. | Stevens Brent M Director,TenPercentOwner | 卖出（S） | 100,000 | US$10.65 | US$106.5万 | 597,155 | SEC |
| 2026-06-10 2026-06-12 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 14,715 | US$4.02 | US$59,154.30 | 7,338,548 | SEC |
| 2026-06-10 2026-06-11 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 29,430 | US$4.02 | US$118,308.60 | 7,353,263 | SEC |
| 2026-06-10 2026-06-11 | BBCP Concrete Pumping Holdings, Inc. | Stevens Brent M Director,TenPercentOwner | 卖出（S） | 50,000 | US$10.53 | US$526,500.00 | 697,155 | SEC |
| 2026-06-09 2026-06-11 | BBCP Concrete Pumping Holdings, Inc. | Stevens Brent M Director,TenPercentOwner | 卖出（S） | 50,000 | US$10.65 | US$532,500.00 | 747,155 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 3,820 | US$270.38 | US$103.29万 | 1,120 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | OYLER JOHN Director,Officer · Chief Executive Officer | 卖出（S） | 1,120 | US$271.14 | US$303,676.80 | 0 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Ball Titus B. Officer · Principal Accounting Officer | 卖出（S） | 36 | US$272.08 | US$9,794.88 | 0 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Ball Titus B. Officer · Principal Accounting Officer | 卖出（S） | 100 | US$271.06 | US$27,106.00 | 36 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Wu Xiaobin Officer · President and COO | 卖出（S） | 1,444 | US$269.33 | US$388,912.52 | 40 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Wu Xiaobin Officer · President and COO | 卖出（S） | 40 | US$270.55 | US$10,822.00 | 0 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Wang Lai Officer · President, Global Head of R&D | 卖出（S） | 40 | US$270.73 | US$10,829.20 | 0 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Wang Lai Officer · President, Global Head of R&D | 卖出（S） | 1,327 | US$269.34 | US$357,414.18 | 40 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 711 | US$270.24 | US$192,140.64 | 160 | SEC |
| 2026-06-08 2026-06-10 | ONC BeOne Medicines Ltd. | Lee Chan Henry Officer · SVP, General Counsel | 卖出（S） | 160 | US$271.26 | US$43,401.60 | 0 | SEC |
| 2026-06-08 2026-06-09 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 23,451 | US$5.38 | US$126,166.38 | 259,527 | SEC |
| 2026-06-05 2026-06-05 | CLF CLEVELAND-CLIFFS INC. | Goncalves Celso L Jr Officer · EVP, CFO | 卖出（S） | 214,308 | US$13.41 | US$287.39万 | 184,541.61 | SEC |
| 2026-06-04 2026-06-08 | MCHP MICROCHIP TECHNOLOGY INC | Simoncic Richard J Officer · CHIEF OPERATING OFFICER | 卖出（S） | 5,000 | US$97.52 | US$487,600.00 | 130,508 | SEC |
| 2026-06-04 2026-06-05 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 12,000 | US$4.75 | US$57,000.00 | 10,579,858 | SEC |
| 2026-06-04 2026-06-05 | CGON CG Oncology, Inc. | POST LEONARD E Director | 卖出（S） | 1,000 | US$54.50 | US$54,500.00 | 0 | SEC |
| 2026-06-01 2026-06-04 | SR SPIRE INC | KOONCE PAUL D Director | 买入（P） | 500 | US$80.50 | US$40,250.00 | 7,500 | SEC |
| 2026-06-01 2026-06-03 | ONC BeOne Medicines Ltd. | Yi Qingqing Director | 卖出（S） | 235 | US$279.13 | US$65,595.55 | 0 | SEC |
| 2026-06-01 2026-06-02 | CON Concentra Group Holdings Parent, Inc. | ORTENZIO ROBERT A Director | 卖出（S） | 130,000 | US$25.00 | US$325万 | 763,455 | SEC |
| 2026-06-01 2026-06-01 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 50,000 | US$3.56 | US$178,000.00 | 7,323,833 | SEC |
| 2026-05-28 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 61,202 | US$3.02 | US$184,830.04 | 7,273,833 | SEC |
| 2026-05-27 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 49,810 | US$2.87 | US$142,954.70 | 7,212,631 | SEC |
| 2026-05-26 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 4,508 | US$2.79 | US$12,577.32 | 7,162,821 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | 667, L.P. Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Brothers Life Sciences LP Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Bros. Advisors (GP) LLC Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER FELIX Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER JULIAN Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,326 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | 667, L.P. Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Brothers Life Sciences LP Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Bros. Advisors (GP) LLC Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER FELIX Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER JULIAN Director | 卖出（S） | 2,743 | US$23.85 | US$65,420.55 | 145,322 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | 667, L.P. Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Brothers Life Sciences LP Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Bros. Advisors (GP) LLC Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER FELIX Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER JULIAN Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,570 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | 667, L.P. Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Brothers Life Sciences LP Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Baker Bros. Advisors (GP) LLC Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER FELIX Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | BAKER JULIAN Director | 卖出（S） | 2,756 | US$23.79 | US$65,565.24 | 142,566 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. Director | 卖出（S） | 212 | US$309.59 | US$65,633.08 | 0 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Riva Alessandro Director | 卖出（S） | 212 | US$309.51 | US$65,616.12 | 0 | SEC |
| 2026-05-22 2026-05-27 | ONC BeOne Medicines Ltd. | Dugan Margaret Director | 卖出（S） | 212 | US$309.60 | US$65,635.20 | 0 | SEC |
| 2026-05-22 2026-05-26 | MCHP MICROCHIP TECHNOLOGY INC | Simoncic Richard J Officer · CHIEF OPERATING OFFICER | 卖出（S） | 5,000 | US$93.44 | US$467,200.00 | 135,508 | SEC |
| 2026-05-21 2026-05-22 | KURA Kura Oncology, Inc. | Powl Brian T. Officer · Chief Commercial Officer | 卖出（S） | 10,000 | US$11.00 | US$110,000.00 | 173,614 | SEC |
| 2026-05-20 2026-05-21 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 33,500 | US$4.07 | US$136,345.00 | 10,567,858 | SEC |
| 2026-05-19 2026-05-21 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 5,000 | US$4.05 | US$20,250.00 | 10,534,358 | SEC |
| 2026-05-19 2026-05-20 | TOI Oncology Institute, Inc. | Chernett Jorey TenPercentOwner | 买入（P） | 30,000 | US$4.09 | US$122,700.00 | 10,529,358 | SEC |
| 2026-05-19 2026-05-20 | KURA Kura Oncology, Inc. | Powl Brian T. Officer · Chief Commercial Officer | 卖出（S） | 339 | US$9.21 | US$3,122.19 | 183,614 | SEC |
| 2026-05-19 2026-05-20 | KURA Kura Oncology, Inc. | FORD KATHLEEN Officer · Chief Operating Officer | 卖出（S） | 2,257 | US$9.08 | US$20,493.56 | 153,560 | SEC |
| 2026-05-18 2026-05-20 | KURA Kura Oncology, Inc. | Bair Teresa Brophy Officer · Chief Legal Officer | 卖出（S） | 2,256 | US$9.38 | US$21,161.28 | 226,931 | SEC |
| 2026-05-15 2026-05-19 | MCHP MICROCHIP TECHNOLOGY INC | Simoncic Richard J Officer · CHIEF OPERATING OFFICER | 卖出（S） | 83 | US$93.85 | US$7,789.55 | 140,261 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ONCY | 286,149 | 2,800 | 560,684.8328 | 51.04% | B, Q, N |
| IONC | 1,023 | 0 | 2,052.093 | 49.85% | Q |
| ONC | 33,349.1954 | 0 | 103,209.0492 | 32.31% | B, Q, N |
| ONCO | 7,096 | 518 | 58,971.4413 | 12.03% | Q, N |
| ONCH | 1,001 | 0 | 172,707 | 0.58% | Q |